Multimodality Stacking with Blockwise missing values and application to the PIONeeR biomarkers study for prediction of resistance to immunotherapy
- URL: http://arxiv.org/abs/2605.25050v1
- Date: Sun, 24 May 2026 12:48:38 GMT
- Title: Multimodality Stacking with Blockwise missing values and application to the PIONeeR biomarkers study for prediction of resistance to immunotherapy
- Abstract summary: We introduce Multimodality Stacking with Blockwise missing values (MSB), a late-fusion framework for survival analysis.<n>MSB independently models modality-specific features before aggregating predictions via a cross-validated stacking meta-learner.<n>MSB was validated on the PIONeeR study to predict progression-free survival in lung cancer patients.
- Score: 0.0
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Integrating multimodal datasets in clinical oncology is frequently hindered by high dimensionality and blockwise missingness, where entire data sources are unavailable for specific patient subsets. Standard survival models often struggle with these gaps, leading to biased results or patient exclusion. We introduce Multimodality Stacking with Blockwise missing values (MSB), a late-fusion framework for survival analysis that independently models modality-specific features before aggregating predictions via a cross-validated stacking meta-learner. MSB was validated on the PIONeeR study (n=443 patients, 378 biomarkers across eight heterogeneous sources) to predict progression-free survival in advanced non-small cell lung cancer patients receiving immunotherapy. MSB yielded higher predictive performance (C-index) than baseline algorithms. Improvements varied by baseline strength: linear models showed a 15.9% increase (p<0.001 for the Wilcoxon signed-rank test), random survival forests gained 5.4% (p=0.002), and gradient boosting methods improved by 2.1% (p=0.030). Beyond discrimination, MSB reduced the generalization gap (train-test difference in 5 folds cross-validation repeated 3 times: 0.055 vs 0.380 for linear models). Permutation importance analysis identified routine laboratory markers, clinical features, and PD-L1 expression as primary predictive drivers. Missing block indicators showed negligible importance, suggesting the model learned from biomarker values rather than data availability patterns. MSB provides a statistically validated framework for multimodal survival prediction with blockwise missingness. By enabling systematic biomarker evaluation without requiring complete data, MSB offers a practical tool for predictive modeling in biomedical research, pending external validation. Implementation is available at https://github.com/MohamedBoussena/MSB under Inria license.
Related papers
- Benchmarking Machine Learning Models for Multi-Omics-Based Breast Cancer Prediction [0.0]
Estrogen Receptor (ER) status is a critical biomarker in breast cancer diagnosis, prognosis, and treatment selection.<n>This study presents a systematic benchmarking analysis of classical machine learning models for ER status prediction.
arXiv Detail & Related papers (2026-06-27T02:46:40Z) - Bootstrapping-based Regularisation for Reducing Individual Prediction Instability in Clinical Risk Prediction Models [2.1127261244588156]
We propose a novel bootstrapping-based regularisation framework that embeds the bootstrapping process directly into the training of deep neural networks.<n>This approach constrains prediction variability across resampled datasets, producing a single model with inherent stability properties.<n>We evaluated models constructed using the proposed regularisation approach against conventional and ensemble models.
arXiv Detail & Related papers (2026-02-11T20:47:30Z) - Investigating the Impact of Histopathological Foundation Models on Regressive Prediction of Homologous Recombination Deficiency [52.50039435394964]
We systematically evaluate foundation models for regression-based tasks.<n>We extract patch-level features from whole slide images (WSI) using five state-of-the-art foundation models.<n>Models are trained to predict continuous HRD scores based on these extracted features across breast, endometrial, and lung cancer cohorts.
arXiv Detail & Related papers (2026-01-29T14:06:50Z) - Transparent Early ICU Mortality Prediction with Clinical Transformer and Per-Case Modality Attribution [42.85462513661566]
We present a lightweight, transparent multimodal ensemble that fuses physiological time-series measurements with unstructured clinical notes from the first 48 hours of an ICU stay.<n>A logistic regression model combines predictions from two modality-specific models: a bidirectional LSTM for vitals and a finetuned ClinicalModernBERT transformer for notes.<n>On the MIMIC-III benchmark, our late-fusion ensemble improves discrimination over the best single model while maintaining well-calibrated predictions.
arXiv Detail & Related papers (2025-11-19T20:11:49Z) - Assessing the Feasibility of Early Cancer Detection Using Routine Laboratory Data: An Evaluation of Machine Learning Approaches on an Imbalanced Dataset [0.02030567625639093]
The development of accessible screening tools for early cancer detection in dogs represents a significant challenge in veterinary medicine.<n>This study assesses the feasibility of cancer risk classification using the Golden Retriever Lifetime Study cohort under real-world constraints.<n>It is concluded that while a statistically detectable cancer signal exists in routine lab data, it is too weak and confounded for clinically reliable discrimination from normal aging or other inflammatory conditions.
arXiv Detail & Related papers (2025-10-23T04:52:42Z) - Advancing Tabular Stroke Modelling Through a Novel Hybrid Architecture and Feature-Selection Synergy [0.9999629695552196]
The present work develops and validates a data-driven and interpretable machine-learning framework designed to predict strokes.<n>Ten routinely gathered demographic, lifestyle, and clinical variables were sourced from a public cohort of 4,981 records.<n>The proposed model achieved an accuracy rate of 97.2% and an F1-score of 97.15%, indicating a significant enhancement compared to the leading individual model.
arXiv Detail & Related papers (2025-05-18T21:46:45Z) - Machine Learning for ALSFRS-R Score Prediction: Making Sense of the Sensor Data [44.99833362998488]
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease that presents individuals with limited treatment options.
The present investigation, spearheaded by the iDPP@CLEF 2024 challenge, focuses on utilizing sensor-derived data obtained through an app.
arXiv Detail & Related papers (2024-07-10T19:17:23Z) - Using Pre-training and Interaction Modeling for ancestry-specific disease prediction in UK Biobank [69.90493129893112]
Recent genome-wide association studies (GWAS) have uncovered the genetic basis of complex traits, but show an under-representation of non-European descent individuals.
Here, we assess whether we can improve disease prediction across diverse ancestries using multiomic data.
arXiv Detail & Related papers (2024-04-26T16:39:50Z) - An Interpretable Web-based Glioblastoma Multiforme Prognosis Prediction
Tool using Random Forest Model [1.1024591739346292]
We propose predictive models that estimate GBM patients' health status of one-year after treatments.
We used total of 467 GBM patients' clinical profile consists of 13 features and two follow-up dates.
Our machine learning models suggest that the top three prognostic factors for GBM patient survival were MGMT gene promoter, the extent of resection, and age.
arXiv Detail & Related papers (2021-08-30T07:56:34Z) - Bootstrapping Your Own Positive Sample: Contrastive Learning With
Electronic Health Record Data [62.29031007761901]
This paper proposes a novel contrastive regularized clinical classification model.
We introduce two unique positive sampling strategies specifically tailored for EHR data.
Our framework yields highly competitive experimental results in predicting the mortality risk on real-world COVID-19 EHR data.
arXiv Detail & Related papers (2021-04-07T06:02:04Z) - UNITE: Uncertainty-based Health Risk Prediction Leveraging Multi-sourced
Data [81.00385374948125]
We present UNcertaInTy-based hEalth risk prediction (UNITE) model.
UNITE provides accurate disease risk prediction and uncertainty estimation leveraging multi-sourced health data.
We evaluate UNITE on real-world disease risk prediction tasks: nonalcoholic fatty liver disease (NASH) and Alzheimer's disease (AD)
UNITE achieves up to 0.841 in F1 score for AD detection, up to 0.609 in PR-AUC for NASH detection, and outperforms various state-of-the-art baselines by up to $19%$ over the best baseline.
arXiv Detail & Related papers (2020-10-22T02:28:11Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.